Developer seeks permission for new homes on farmland
- Credit: Archant
Plans for a new housing development in Upware have been submitted to planning officials.
Emma Cross, of Isleham, has applied to East Cambridgeshire District Council for outline planning permission a development of four single-storey homes, including two affordable properties, off Upware Road.
The land, which extends to about three-quarters of an acre, is currently used for agriculture.
Agents acting for the applicant told the council: “Our proposals are only small scale in nature. The two market houses proposed reflect the suggested maximum housing schemes within the development envelope should be limited to, whilst the two social houses add more affordable housing stock to the village.
“The public footway proposed to the west of Upware Road will increase pedestrian safety within the vicinity, and the CIL payments associated with such a development could be put towards the some of the other suggested improvements within the village.
You may also want to watch:
“The effect of the proposed development on the surrounding properties and land owners would be minimal as the proposals are only single storey in nature, and would be landscaped in a manner to reduce any impact.”
A decision is expected on the plans within the next eight weeks. To view the plans, or to have a say, visit www.eastcambs.gov.uk
- 1 Binmen revolt over alleged bullying, poor pay, low morale and staffing crisis
- 2 Woman pedestrian in her 50s killed in guided busway crash
- 3 Plans revealed for new A10 pedestrian bridge
- 4 Ely Cathedral hosts legendary jockey Frankie Dettori's only book signing
- 5 Retired murder detective, Russell, releases first book in new crime series
- 6 'I feel alive for the first time': Slimmer lost half his body weight in lockdown
- 7 Woman has heart attack and dies in ambulance waiting for a hospital bed
- 8 Memorial stone for Cambridge student laid hidden in undergrowth for 80 years
- 9 Cambridgeshire hospitals busy and staff tired and abused
- 10 Covid-19 vaccine myths ‘biggest challenge’ in progress